-
Je něco špatně v tomto záznamu ?
Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis
R. Ciccocioppo, C. Mengoli, E. Betti, G. Comolli, I. Cassaniti, A. Piralla, P. Kruzliak, M. Caprnda, L. Pozzi, GR. Corazza, A. Di Sabatino, F. Baldanti
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články
Grantová podpora
08064415
Fondazione IRCCS Policlinico San Matteo
- MeSH
- CD4-pozitivní T-lymfocyty metabolismus MeSH
- CD8-pozitivní T-lymfocyty metabolismus MeSH
- cytomegalovirové infekce farmakoterapie imunologie MeSH
- Cytomegalovirus imunologie fyziologie MeSH
- DNA virů genetika MeSH
- infekce virem Epsteina-Barrové farmakoterapie imunologie MeSH
- lidé MeSH
- prospektivní studie MeSH
- steroidy škodlivé účinky terapeutické užití MeSH
- studie případů a kontrol MeSH
- ulcerózní kolitida farmakoterapie imunologie virologie MeSH
- virová nálož MeSH
- virus Epsteinův-Barrové imunologie fyziologie MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Human Cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) are endowed with the ability of establishing lifelong latency in human hosts and reactivating in immunocompromised subjects, including patients suffering from ulcerative colitis (UC). We, therefore, aimed to investigate virus-specific immunity in UC patients. A cohort of 24 UC patients (14 responders and 10 refractory to therapy) and 26 control subjects was prospectively enrolled to undergo virus-specific serology (by ELISA assay) and assessment of both CD4+ and CD8+ virus-specific T-cell response (by interferon-γ enzyme-linked immunospotanalysis). In parallel, mucosal viral load was determined by quantitative real-time PCR and the values were correlated with both clinical and endoscopic indexes of activity. For statistics, the t-test, Mann-Withney test, Fisher's exact test and Spearman rank correlation test were applied; p < 0.05 was considered significant. EBV-specific CD4+ and CD8+ T-cell responses were significantly lower in UC patients compared to controls (p < 0.0001 and p = 0.0006, respectively), whereas no difference was found for HCMV-specific T-cell response. When dividing the UC group according to response to therapy, both responders and refractory UC patients showed a deficient EBV-specific CD4+ T-cell response with respect to controls (p < 0.04 and p = 0.0003, respectively). Moreover, both EBV and HCMV mucosal loads were significantly higher in refractory UC than in responders and controls (p = 0.007 and 0.003; and p = 0.02 and 0.001, respectively), and correlated with activity indexes. Steroid therapy seemed the main risk factor for triggering EBV colitis. Finally, no cases of IgM positivity were found in the study population. An impaired EBV-specific immunity was clearly evident in UC patients, mostly in those refractory to therapy. The ELISPOT assay may serve as new tool for quantifying and monitoring virus-specific T-cell immunity in UC.
Department of Clinical Surgical Diagnostics and Pediatric Sciences University of Pavia Pavia Italy
Department of Internal Medicine San Matteo Hospital Foundation University of Pavia Pavia Italy
Experimental Research Laboratories Biotechnology Area San Matteo Hospital Foundation Pavia Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22012310
- 003
- CZ-PrNML
- 005
- 20220506130301.0
- 007
- ta
- 008
- 220425s2021 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10238-021-00702-2 $2 doi
- 035 __
- $a (PubMed)33772380
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Ciccocioppo, Rachele $u Gastroenterology Unit, Department of Medicine, A.O.U.I. Policlinico G.B. Rossi, University of Verona, Piazzale L.A. Scuro, 10, 37134, Verona, Italy. rachele.ciccocioppo@univr.it
- 245 10
- $a Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis / $c R. Ciccocioppo, C. Mengoli, E. Betti, G. Comolli, I. Cassaniti, A. Piralla, P. Kruzliak, M. Caprnda, L. Pozzi, GR. Corazza, A. Di Sabatino, F. Baldanti
- 520 9_
- $a Human Cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) are endowed with the ability of establishing lifelong latency in human hosts and reactivating in immunocompromised subjects, including patients suffering from ulcerative colitis (UC). We, therefore, aimed to investigate virus-specific immunity in UC patients. A cohort of 24 UC patients (14 responders and 10 refractory to therapy) and 26 control subjects was prospectively enrolled to undergo virus-specific serology (by ELISA assay) and assessment of both CD4+ and CD8+ virus-specific T-cell response (by interferon-γ enzyme-linked immunospotanalysis). In parallel, mucosal viral load was determined by quantitative real-time PCR and the values were correlated with both clinical and endoscopic indexes of activity. For statistics, the t-test, Mann-Withney test, Fisher's exact test and Spearman rank correlation test were applied; p < 0.05 was considered significant. EBV-specific CD4+ and CD8+ T-cell responses were significantly lower in UC patients compared to controls (p < 0.0001 and p = 0.0006, respectively), whereas no difference was found for HCMV-specific T-cell response. When dividing the UC group according to response to therapy, both responders and refractory UC patients showed a deficient EBV-specific CD4+ T-cell response with respect to controls (p < 0.04 and p = 0.0003, respectively). Moreover, both EBV and HCMV mucosal loads were significantly higher in refractory UC than in responders and controls (p = 0.007 and 0.003; and p = 0.02 and 0.001, respectively), and correlated with activity indexes. Steroid therapy seemed the main risk factor for triggering EBV colitis. Finally, no cases of IgM positivity were found in the study population. An impaired EBV-specific immunity was clearly evident in UC patients, mostly in those refractory to therapy. The ELISPOT assay may serve as new tool for quantifying and monitoring virus-specific T-cell immunity in UC.
- 650 _2
- $a CD4-pozitivní T-lymfocyty $x metabolismus $7 D015496
- 650 _2
- $a CD8-pozitivní T-lymfocyty $x metabolismus $7 D018414
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a ulcerózní kolitida $x farmakoterapie $x imunologie $x virologie $7 D003093
- 650 _2
- $a Cytomegalovirus $x imunologie $x fyziologie $7 D003587
- 650 _2
- $a cytomegalovirové infekce $x farmakoterapie $x imunologie $7 D003586
- 650 _2
- $a DNA virů $x genetika $7 D004279
- 650 _2
- $a infekce virem Epsteina-Barrové $x farmakoterapie $x imunologie $7 D020031
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a virus Epsteinův-Barrové $x imunologie $x fyziologie $7 D004854
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a prospektivní studie $7 D011446
- 650 _2
- $a steroidy $x škodlivé účinky $x terapeutické užití $7 D013256
- 650 _2
- $a virová nálož $7 D019562
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Mengoli, Caterina $u Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy
- 700 1_
- $a Betti, Elena $u Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy
- 700 1_
- $a Comolli, Giuditta $u Molecular Virology Unit, Microbiology and Virology Department, San Matteo Hospital Foundation, Pavia, Italy $u Experimental Research Laboratories, Biotechnology Area, San Matteo Hospital Foundation, Pavia, Italy
- 700 1_
- $a Cassaniti, Irene $u Molecular Virology Unit, Microbiology and Virology Department, San Matteo Hospital Foundation, Pavia, Italy
- 700 1_
- $a Piralla, Antonio $u Molecular Virology Unit, Microbiology and Virology Department, San Matteo Hospital Foundation, Pavia, Italy
- 700 1_
- $a Kruzliak, Peter $u 2Nd Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekarska 53, 65691, Brno, Czech Republic. kruzliakpeter@gmail.com $1 https://orcid.org/0000000270693784
- 700 1_
- $a Caprnda, Martin $u First Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia
- 700 1_
- $a Pozzi, Lodovica $u Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy
- 700 1_
- $a Corazza, Gino Roberto $u Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy
- 700 1_
- $a Di Sabatino, Antonio $u Department of Internal Medicine, San Matteo Hospital Foundation, University of Pavia, Pavia, Italy
- 700 1_
- $a Baldanti, Fausto $u Molecular Virology Unit, Microbiology and Virology Department, San Matteo Hospital Foundation, Pavia, Italy $u Department of Clinical, Surgical, Diagnostics and Pediatric Sciences, University of Pavia, Pavia, Italy
- 773 0_
- $w MED00006222 $t Clinical and experimental medicine $x 1591-9528 $g Roč. 21, č. 3 (2021), s. 379-388
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33772380 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130253 $b ABA008
- 999 __
- $a ok $b bmc $g 1789758 $s 1163511
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 21 $c 3 $d 379-388 $e 20210326 $i 1591-9528 $m Clinical and Experimental Medicine $n Clin Exp Med $x MED00006222
- GRA __
- $a 08064415 $p Fondazione IRCCS Policlinico San Matteo
- LZP __
- $a Pubmed-20220425